HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of urinary versus recombinant follicle-stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulation.

AbstractOBJECTIVE:
To determine the effect of urinary versus recombinant FSH on platelet function and hemostatic variables in women undergoing controlled ovarian hyperstimulation cycles.
DESIGN:
Randomized clinical study.
SETTING:
Major university-based infertility and in vitro fertilization unit and hemostasis laboratory.
PATIENT(S):
Ten healthy women (in vitro study), and 24 women undergoing routine controlled ovarian hyperstimulation cycles (in vivo study), randomly assigned to receive either urinary (u-FSH) or recombinant gonadotropin (r-FSH).
INTERVENTION(S):
In vitro study: effect of preincubation of plasma with u-FSH or r-FSH, in the presence or absence of estradiol, on platelet function and coagulation parameters. In vivo study: Changes in platelet function and coagulation parameters after treatment with u-FSH or r-FSH during controlled ovarian hyperstimulation cycles.
MAIN OUTCOME MEASURE(S):
Platelet aggregation and ATP release, activated protein C resistance ratio, free protein S.
RESULT(S):
In vitro study: Platelet aggregation and ATP release were significantly inhibited by u-FSH relative to r-FSH in both the presence and absence of estradiol (P=.047). In vivo study: Platelet function was significantly inhibited after treatment with u-FSH (P=.05) but not with r-FSH. In both studies, small changes of minor clinical significance were noted in activated protein C resistance and free protein S levels.
CONCLUSION(S):
The different platelet response to u-FSH and r-FSH may have clinical implications in selected patients, especially those at risk of thromboembolic complications, in decisions regarding the appropriate medication for controlled ovarian hyperstimulation cycles.
AuthorsJacob Bar, Raoul Orvieto, Judith Lahav, Moshe Hod, Boris Kaplan, Benjamin Fisch
JournalFertility and sterility (Fertil Steril) Vol. 82 Issue 6 Pg. 1564-9 (Dec 2004) ISSN: 0015-0282 [Print] United States
PMID15589861 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Follicle Stimulating Hormone, Human
  • Protein S
  • Recombinant Proteins
  • Estradiol
  • Menotropins
  • Adenosine Triphosphate
  • Follicle Stimulating Hormone
Topics
  • Activated Protein C Resistance
  • Adenosine Triphosphate (antagonists & inhibitors)
  • Adult
  • Blood Platelets (drug effects)
  • Drug Therapy, Combination
  • Estradiol (therapeutic use)
  • Female
  • Follicle Stimulating Hormone (therapeutic use, urine)
  • Follicle Stimulating Hormone, Human (therapeutic use)
  • Hemostasis (drug effects)
  • Humans
  • Infertility (blood, drug therapy, physiopathology)
  • Menotropins (therapeutic use)
  • Ovulation Induction
  • Platelet Aggregation (drug effects)
  • Protein S (metabolism)
  • Recombinant Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: